Literature DB >> 7798415

Oral transmucosal fentanyl citrate premedication in patients undergoing outpatient dermatologic procedures.

J W Gerwels1, J L Bezzant, L Le Maire, L F Pauley, J B Streisand.   

Abstract

BACKGROUND: Oral transmucosal fentanyl citrate (OTFC) is a novel lozenge dosage form of fentanyl used for premedication. Many dermatology patients undergoing surgical procedures could benefit from such a medication.
OBJECTIVE: The study compared the safety and efficacy of 400-vs 800-micrograms dosage forms for their sedative and anxiolytic effects in adults undergoing a variety of dermatologic outpatient surgical procedures.
METHODS: Patients received OTFC 30 minutes before the procedure. Vital signs, oxygen saturation, sedation, and anxiety scores were measured before OTFC administration and every 15 minutes thereafter.
RESULTS: Significant sedation and anxiolysis developed in both dosage groups. No clinically significant changes in respiratory rate, heart rate, or blood pressure occurred during the study period. Common drug-induced side effects included dizziness, nausea, pruritus, and vomiting.
CONCLUSION: OTFC is safe and effective for outpatient dermatologic procedures; however, the risk of opioid-related side effects must be carefully weighed against the benefits when deciding to use OTFC in an outpatient setting.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7798415     DOI: 10.1111/j.1524-4725.1994.tb03712.x

Source DB:  PubMed          Journal:  J Dermatol Surg Oncol        ISSN: 0148-0812


  2 in total

1.  Designing sedative/hypnotic compounds from a novel substructural graph-theoretical approach.

Authors:  E Estrada; A Peña; R García-Domenech
Journal:  J Comput Aided Mol Des       Date:  1998-11       Impact factor: 3.686

Review 2.  Advanced and controlled drug delivery systems in clinical disease management.

Authors:  J R Brouwers
Journal:  Pharm World Sci       Date:  1996-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.